Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	95.34	129.77	66.43
Graham Fair Price	-27.60	1106.02	1527.60
PEG	-95.01	-0.91	18.33
Price/Book	4.80	1.49	1.42
Price/Cash Flow	inf	0.00	571.04
Prices/Earnings	105.76	44.17	21.47
Price/Sales	13.84	2.68	2.36
Price/FCF	inf	0.00	571.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-0.68	0.10	0.10
Operating Margin	-22.68	0.02	0.03
ROA	-44.68	< 0.005	< 0.005
ROE	0.02	< 0.005	-49.07
ROIC	< 0.005	< 0.005	-27.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.20	0.13	52.26
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	-0.28	-47.78
EPS QOQ	0.01	-0.48	4026.66
FCF QOQ	0.03	0.00	inf
Revenue QOQ	-0.06	-0.07	-9.83
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.08	68.38	5.07
Days Sales Outstanding (DSO)	85.48	101.85	19.15
Inventory Turnover	1.38	1.32	-4.83
Debt/Capitalization	0.41	0.35	-13.94
Quick Ratio	0.88	0.98	11.09
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	2501.40	2537.71	1.45
Cash	804.81	507.25	-36.97
Capex	0.00	n.A.	n.A.
Free Cash Flow	6.23	n.A.	n.A.
Revenue	1510.11	1410.39	-6.60
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.39	1.46	4.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.62	24.26	92.26
Naive Interpretation	Member

06 - Financial Health · Weak

Rating